147 filings
424B3
ESLA
Estrella Immunopharma Inc
15 May 24
Prospectus supplement
4:21pm
10-Q
2024 Q3
ESLA
Estrella Immunopharma Inc
Quarterly report
14 May 24
9:49pm
8-K
ESLA
Estrella Immunopharma Inc
13 May 24
Entry into a Material Definitive Agreement
5:28pm
8-K
ESLA
Estrella Immunopharma Inc
10 Apr 24
Regulation FD Disclosure
6:14am
424B3
ESLA
Estrella Immunopharma Inc
8 Mar 24
Prospectus supplement
9:28pm
8-K
fr8v4 4kp
8 Mar 24
Other Events
9:25pm
424B3
za61pkkoegfnq5n
7 Mar 24
Prospectus supplement
4:04pm
8-K
x2n5 pk47razn
6 Mar 24
Entry into a Material Definitive Agreement
9:49pm
424B3
s08anzeyipyegs6
15 Feb 24
Prospectus supplement
7:11pm
424B3
pq8uu6p743ik4
12 Feb 24
Prospectus supplement
5:02pm
8-K
5emrcg ow
2 Feb 24
Changes in Registrant's Certifying Accountant
8:30am
8-K
9zs76ley
30 Jan 24
Estrella Immunopharma Announces $1 Million Share Repurchase Authorization
11:29am
EFFECT
pumr0
29 Dec 23
Notice of effectiveness
12:15am
424B3
7vtsa 6d2s65
28 Dec 23
Prospectus supplement
4:56pm
CORRESP
0w1xq wu8
27 Dec 23
Correspondence with SEC
12:00am
CORRESP
l06cl2q tyvhrua8
15 Dec 23
Correspondence with SEC
12:00am
UPLOAD
ue7nl4j
21 Nov 23
Letter from SEC
12:00am